These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

705 related articles for article (PubMed ID: 34532856)

  • 1. The role of neuroimaging in Parkinson's disease.
    Bidesi NSR; Vang Andersen I; Windhorst AD; Shalgunov V; Herth MM
    J Neurochem; 2021 Nov; 159(4):660-689. PubMed ID: 34532856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imaging in Parkinson's Disease.
    Politis M; Pagano G; Niccolini F
    Int Rev Neurobiol; 2017; 132():233-274. PubMed ID: 28554409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational molecular imaging and drug development in Parkinson's disease.
    Haider A; Elghazawy NH; Dawoud A; Gebhard C; Wichmann T; Sippl W; Hoener M; Arenas E; Liang SH
    Mol Neurodegener; 2023 Feb; 18(1):11. PubMed ID: 36759912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron Emission Tomography Imaging of Synaptic Dysfunction in Parkinson's Disease.
    Niu J; Zhong Y; Jin C; Cen P; Wang J; Cui C; Xue L; Cui X; Tian M; Zhang H
    Neurosci Bull; 2024 Jun; 40(6):743-758. PubMed ID: 38483697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of PET and SPECT to the understanding of the pathophysiology of Parkinson's disease.
    Thobois S; Guillouet S; Broussolle E
    Neurophysiol Clin; 2001 Oct; 31(5):321-40. PubMed ID: 11817273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of dopaminergic brain imaging in Parkinson's disease.
    Seibyl J; Russell D; Jennings D; Marek K
    Q J Nucl Med Mol Imaging; 2012 Feb; 56(1):4-16. PubMed ID: 22460156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroimaging approaches to cognition in Parkinson's disease.
    Montaser-Kouhsari L; Young CB; Poston KL
    Prog Brain Res; 2022; 269(1):257-286. PubMed ID: 35248197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of biomarkers and imaging in Parkinson's disease.
    Algarni MA; Stoessl AJ
    Expert Rev Neurother; 2016; 16(2):187-203. PubMed ID: 26829357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in Parkinsonian Disorders.
    Tripathi M; Kumar A; Bal C
    Neurol India; 2018; 66(Supplement):S68-S78. PubMed ID: 29503329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear imaging in Parkinson's disease: The past, the present, and the future.
    Golan H; Volkov O; Shalom E
    J Neurol Sci; 2022 May; 436():120220. PubMed ID: 35313223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research progress in the early diagnosis of Parkinson's disease.
    Xie L; Hu L
    Neurol Sci; 2022 Nov; 43(11):6225-6231. PubMed ID: 35948779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging neurodegeneration in Parkinson's disease.
    Pavese N; Brooks DJ
    Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Future of Brain Imaging in Parkinson's Disease.
    Helmich RC; Vaillancourt DE; Brooks DJ
    J Parkinsons Dis; 2018; 8(s1):S47-S51. PubMed ID: 30584163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroimaging of Parkinson's disease: Expanding views.
    Weingarten CP; Sundman MH; Hickey P; Chen NK
    Neurosci Biobehav Rev; 2015 Dec; 59():16-52. PubMed ID: 26409344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroimaging for Lewy body disease: is the in vivo molecular imaging of α-synuclein neuropathology required and feasible?
    Vernon AC; Ballard C; Modo M
    Brain Res Rev; 2010 Oct; 65(1):28-55. PubMed ID: 20685363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimaging Advances in Parkinson's Disease and Atypical Parkinsonian Syndromes.
    Saeed U; Lang AE; Masellis M
    Front Neurol; 2020; 11():572976. PubMed ID: 33178113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotracers for imaging of Parkinson's disease.
    Abbasi Gharibkandi N; Hosseinimehr SJ
    Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional imaging in Parkinson's disease.
    Dagher A
    Semin Neurol; 2001; 21(1):23-32. PubMed ID: 11346022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and dopamine transporter neuroimaging: a critical review.
    Shih MC; Hoexter MQ; Andrade LA; Bressan RA
    Sao Paulo Med J; 2006 May; 124(3):168-75. PubMed ID: 17119698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.